scholarly article | Q13442814 |
P50 | author | Bradley C. Bundy | Q45367009 |
Marvin J. Grubman | Q105876327 | ||
P2093 | author name string | Anthony M Bennett | |
Mark T Smith | |||
P2860 | cites work | Transmission pathways of foot-and-mouth disease virus in the United Kingdom in 2007 | Q33329101 |
Toward a global foot and mouth disease vaccine bank network. | Q33453364 | ||
Foot-and-mouth disease: past, present and future | Q33640554 | ||
The pathogenesis of foot-and-mouth disease I: viral pathways in cattle | Q34168021 | ||
The economic impacts of foot and mouth disease - what are they, how big are they and where do they occur? | Q34365052 | ||
Foot-and-mouth disease | Q34547126 | ||
Engineering foot-and-mouth disease viruses with improved growth properties for vaccine development | Q34571663 | ||
A brief history of vaccines and vaccination | Q34651406 | ||
Escherichia coli-based cell-free synthesis of virus-like particles. | Q34714746 | ||
Foot-and-mouth disease virus: biology and prospects for disease control | Q34935334 | ||
Foot and mouth disease virus vaccines | Q35008372 | ||
Review of the status and control of foot and mouth disease in sub-Saharan Africa. | Q35043496 | ||
The economics of foot and mouth disease | Q35043557 | ||
Economic costs of the foot and mouth disease outbreak in the United Kingdom in 2001. | Q35043566 | ||
Control of foot and mouth disease: lessons from the experience of Ireland. | Q35043579 | ||
Control and eradication of foot-and-mouth disease | Q35044863 | ||
Foot and mouth disease in wildlife | Q35044867 | ||
Research in advance for FMD novel vaccines | Q35054750 | ||
The pathogenesis and diagnosis of foot-and-mouth disease. | Q35177505 | ||
A safe foot-and-mouth disease vaccine platform with two negative markers for differentiating infected from vaccinated animals | Q36363420 | ||
Foot-and-mouth disease virus-like particles produced by a SUMO fusion protein system in Escherichia coli induce potent protective immune responses in guinea pigs, swine and cattle | Q37038082 | ||
Foot-and-mouth disease virus concentrations in products of animal origin | Q37132390 | ||
Experimental evaluation of foot-and-mouth disease vaccines for emergency use in ruminants and pigs: a review | Q37224088 | ||
Vaccination against foot-and-mouth disease virus: strategies and effectiveness | Q37403499 | ||
Retrospective evaluation of foot-and-mouth disease vaccine effectiveness in Turkey | Q37709740 | ||
Moving towards the global control of foot and mouth disease: an opportunity for donors. | Q37749775 | ||
Qualitative assessment of the commodity risk for spread of foot-and-mouth disease associated with international trade in deboned beef | Q37766939 | ||
Virus-like particles: potential veterinary vaccine immunogens | Q37958442 | ||
Novel reverse transcription loop-mediated isothermal amplification for rapid detection of foot-and-mouth disease virus. | Q38439070 | ||
Foot-and-mouth disease vaccination in South Sudan: benefit-cost analysis and livelihoods impact | Q39228648 | ||
Clinical manifestations of foot-and-mouth disease during the 2010/2011 epidemic in the Republic of Korea | Q39660548 | ||
The incorporation of the A2 protein to produce novel Qβ virus-like particles using cell-free protein synthesis. | Q39681830 | ||
Evolution of foot-and-mouth disease virus intra-sample sequence diversity during serial transmission in bovine hosts | Q39938731 | ||
Incursions of foot-and-mouth disease virus into Europe between 1985 and 2006. | Q40105205 | ||
Analysis of a foot-and-mouth disease virus type A24 isolate containing an SGD receptor recognition site in vitro and its pathogenesis in cattle | Q40368026 | ||
The carrier state in foot and mouth disease--an immunological review | Q40856150 | ||
Detection of all seven serotypes of foot-and-mouth disease virus by real-time, fluorogenic reverse transcription polymerase chain reaction assay | Q45731361 | ||
Symposium: international challenges and perspectives: internationalism and survival of foot-and-mouth disease virus in cattle and food products | Q45791184 | ||
Host cell selection of antigenic variants of foot-and-mouth disease virus | Q45847273 | ||
Foot-and-mouth disease: current world situation | Q46953963 | ||
Relationship between clinical signs and transmission of an infectious disease and the implications for control. | Q51571274 | ||
Epidemiological characteristics and financial costs of the 1997 foot-and-mouth disease epidemic in Taiwan. | Q55034194 | ||
Assessing risks of disease transmission between wildlife and livestock: The Saiga antelope as a case study | Q56864176 | ||
The UK foot-and-mouth disease outbreak — the aftermath | Q57081239 | ||
Triggers for foot and mouth disease vaccination in the United States | Q57096767 | ||
Reintroduction of foot-and-mouth disease in Argentina: characterisation of the isolates and development of tools for the control and eradication of the disease | Q57649292 | ||
Science for development. Poverty reduction through animal health | Q79599702 | ||
Plasmid encoding papillomavirus Type 16 (HPV16) DNA constructed with codon optimization improved the immunogenicity against HPV infection | Q80998318 | ||
Progressive control of FMD on a global scale | Q84451324 | ||
P433 | issue | 31 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | foot-and-mouth disease | Q152401 |
eradication of infectious diseases | Q1347969 | ||
P1104 | number of pages | 7 | |
P304 | page(s) | 3902-3908 | |
P577 | publication date | 2014-04-28 | |
P1433 | published in | Vaccine | Q7907941 |
P1476 | title | Foot-and-mouth disease: technical and political challenges to eradication | |
P478 | volume | 32 |
Q40085516 | Breaking the chain of zoonoses through biosecurity in livestock |
Q58099534 | Challenges and Opportunities Developing Mathematical Models of Shared Pathogens of Domestic and Wild Animals |
Q37210402 | Complete Genome Sequence of Foot-and-Mouth Disease Virus Serotype SAT3 Zimbabwe/4/81. |
Q36058279 | Evaluation of serological response to foot-and-mouth disease vaccination in BLV infected cows |
Q42176472 | Genetic and immunologic relationships between vaccine and field strains for vaccine selection of type A foot-and-mouth disease virus circulating in East Asia |
Q57025429 | Multi-Target Strategy for Pan/Foot-and-Mouth Disease Virus (FMDV) Detection: A Combination of Sequences Analysis, Predictions and Laboratory Diagnostic Evaluation |
Q40664785 | Novel 6xHis tagged foot-and-mouth disease virus vaccine bound to nanolipoprotein adjuvant via metal ions provides antigenic distinction and effective protective immunity |
Q47320793 | Rapid, portable detection of endocrine disrupting chemicals through ligand-nuclear hormone receptor interactions |
Q89623530 | Retrospect and Risk Analysis of Foot-and-Mouth Disease in China Based on Integrated Surveillance and Spatial Analysis Tools |
Q30252156 | Review of the Global Distribution of Foot-and-Mouth Disease Virus from 2007 to 2014. |
Q40253673 | Safe and cost-effective protocol for shipment of samples from Foot-and-Mouth Disease suspected cases for laboratory diagnostic. |
Q94539244 | The role of viral particle integrity in the serological assessment of foot-and-mouth disease virus vaccine-induced immunity in swine |
Q30235302 | Who acquires infection from whom and how? Disentangling multi-host and multi-mode transmission dynamics in the 'elimination' era. |
Search more.